Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor-Reference-Cited by-同舟云学术

Pamiparib is a potent and selective PARP inhibitor with unique potential for the treatment of brain tumor

Published:2020-09 Issue:9 Volume:22 Page:431-440
ISSN:1476-5586
Container-title:Neoplasia
language:en
Short-container-title:Neoplasia

Author:

Xiong Yao,Guo Yin,Liu Ye,Wang Hexiang,Gong Wenfeng,Liu Yong,Wang Xing,Gao Yajuan,Yu Fenglong,Su Dan,Wang Fan,Zhu Yutong,Zhao Yuan,Wu Yiyuan,Qin Zhen,Sun Xuebing,Ren Bo,Jiang Bin,Jin Wei,Shen Zhirong,Tang Zhiyu,Song Xiaomin,Wang Lai,Liu Xuesong,Zhou Changyou^ORCID,Jiang Beibei

Publisher

Elsevier BV

Subject

Cancer Research

Reference43 articles.

1. Hallmarks of cancer: the next generation;Hanahan;Cell.,2011

2. Homologous recombination in DNA repair and DNA damage tolerance;Li;Cell Res.,2008

3. BRCA1 and BRCA2: 1994 and beyond;Narod;Nat Rev Cancer,2004

4. PARP inhibition: PARP1 and beyond;Rouleau;Nat Rev Cancer,2010

5. PARP inhibitors: synthetic lethality in the clinic;Lord;Science.,2017

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of DNA methylation-regulated WEE1 with potential implications in prognosis and immunotherapy for low-grade glioma;Cancer Biomarkers;2024-08-27

2. Leveraging PARP-1/2 to Target Distant Metastasis;International Journal of Molecular Sciences;2024-08-20

3. Distribution of pamiparib, a novel inhibitor of poly(ADP-ribose)-polymerase (PARP), in tumor tissue analyzed by multimodal imaging;Journal of Pharmaceutical Analysis;2024-08

4. Poly (ADP-ribose) polymerase inhibitor therapy and mechanisms of resistance in epithelial ovarian cancer;Frontiers in Oncology;2024-07-29

5. Case Report of Complete Response to Olaparib in a Patient with Breast Cancer Brain Metastases;Case Reports in Oncology;2024-07-20